<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-10-GHRG_3_133208</iati-identifier>
  <reporting-org ref="GB-GOV-10" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">NIHR Global Health Research Group on developing strategies for hepatitis C in Ethiopia (DESTINE)</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Clinicians and the Ethiopian Government urgently seek the development of a Hepatitis C Virus (HCV) strategy for Ethiopia. 

They have identified the need for implementation and scale-up of testing and treatment, and development of effective preventive strategies. 

The DESTINE project is a collaboration of experts from the Universities of Dundee and Bristol, 4 Ethiopian Medical schools (Universities of Addis Ababa, Gondar, Jimma and Mekele) together with the Ethiopian Public Health and Armauer Hansen Institutes on behalf of the Ethiopian government. 

The team will investigate the extent of HCV infection in Ethiopia using epidemiological and modelling techniques. 

It will design pathways of care based around treatment pathways designed in the UK but moulded to suit the Ethiopian context. 

Ethiopian stakeholders and community members will be intrinsic to the project, ensuring that any outputs take account of local attitudes to provisions of services, stigma, regional and ethnic issues around services. 

The work of the project will inform Ethiopian government strategic planning for HCV. It will also enhance associated research skill sets within the 4 major Ethiopian Medical schools, thereby enhancing the research infrastructure in the country.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Objectives: 
1.	To estimate how common Hepatitis C virus (HCV) infection is in 4 regions across Ethiopia, namely Addis Ababa, Gondar, Mekelle and Jimma. 
2.	To collect demographic data on age, sex, route and stage of infection.
3.	To estimate the risk of new infection, based on route of infection data and surveys of health care practices and other risk factors.
4.	To discover the molecular epidemiology of HCV by region.
5.	To estimate the causal contribution of HCV to incidence of Lymphoma and HCC. 
6.	To model the ongoing HCV epidemic in Ethiopia and the health consequences for those infected.
7.	To model the impact and cost-effectiveness of different testing and treatment strategies.
8.	To model the health economic impacts of different care pathways. 
9.	To develop sustainable public health strategies to prevent further HCV transmission.
10.	To develop models of care suitable for Ethiopian HCV strategy and health care system, utilising learning from international best practice.
11.	To pilot the efficacy and effectiveness of models of care to inform modelling in different environments in Ethiopia.</narrative>
  </description>
  <participating-org ref="GB-GOV-10" role="1" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" role="2" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" role="3" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">University of Dundee</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-10-01" type="1"></activity-date>
  <activity-date iso-date="2021-10-01" type="2"></activity-date>
  <activity-date iso-date="2025-09-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Science, Research and Evidence</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Global Health Research Programme</narrative>
   </person-name>
   <email>GlobalHealthResearch@dhsc.gov.uk</email>
   <website>https://www.nihr.ac.uk/funding-and-support/global-health-research/</website>
   <mailing-address>
    <narrative xml:lang="EN">7th Floor South Wing, 39 Victoria Street, London, SW1H 0EU</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="1027" percentage="100" vocabulary="1"></recipient-region>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <tag code="RI" vocabulary="99" vocabulary-uri="https://devtracker.fcdo.gov.uk/custom-codes">
   <narrative xml:lang="EN">Research and Innovation</narrative>
  </tag>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">241308</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">547372</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">578528</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2024-04-01"></period-start>
   <period-end iso-date="2025-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">501172</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2025-04-01"></period-start>
   <period-end iso-date="2026-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">355802</value>
  </budget>
  <capital-spend percentage="100"></capital-spend>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-26"></transaction-date>
   <value currency="GBP" value-date="2021-11-26">120654</value>
   <description>
    <narrative xml:lang="EN">GB-GOV-10-GHRG_3_133208 2021/22 Q3 DISBURSEMENT</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-10-GHRG_3_133208" ref="GB-GOV-10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Dundee</narrative>
   </receiver-org>
  </transaction>
  <related-activity ref="GB-GOV-10-GHRG_3_132995" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133144" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133205" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133231" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133232" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133333" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GHRG_3_133384" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-NIHR_GHRG3" type="1"></related-activity>
  <conditions attached="0"></conditions>
 </iati-activity>
</iati-activities>
